The fire within: microbes inflame tumors.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Cell

• Publication date

  2014-05-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.cell.2014.03.006PMID 24813605
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/-mice.

  2016cited by this paper
• Elevated serum IL-22 levels correlate with chemoresistant condition of colorectal cancer.

  2013cited by this paper
• Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment

  2013cited by this paper
• NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer.

  2013cited by this paper
• Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model

  2013influential reference
• Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota

  2013cited by this paper
• IL-22 is related to development of human colon cancer by activation of STAT3

  2013cited by this paper
• The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide

  2013cited by this paper
• Innate sensors of pathogen and stress: linking inflammation to obesity.

  2013cited by this paper
• Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer

  2013influential reference
• Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin.

  2013cited by this paper
• Safety, Tolerability, and Clinical Response After Fecal Transplantation in Children and Young Adults With Ulcerative Colitis

  2013cited by this paper
• Duodenal infusion of donor feces for recurrent Clostridium difficile.

  2013cited by this paper
• Alteration of Intestinal Dysbiosis by Fecal Microbiota Transplantation Does not Induce Remission in Patients with Chronic Active Ulcerative Colitis

  2013cited by this paper
• Innate lymphoid cells — how did we miss them?

  2013cited by this paper
• Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment.

  2013cited by this paper
• NLRP6 in infection and inflammation.

  2013cited by this paper
• Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome

  2013cited by this paper
• Interleukin 23 production by intestinal CD103(+)CD11b(+) dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense.

  2012influential reference
• Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota

  2012cited by this paper
• IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine

  2012influential reference
• Dietary fat-induced taurocholic acid production promotes pathobiont and colitis in IL-10−/− mice

  2012cited by this paper
• Inflammasomes: far beyond inflammation

  2012influential reference
• Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease.

  2012cited by this paper
• Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth

  2012influential reference
• The microbiome in infectious disease and inflammation.

  2012cited by this paper
• Life, death, and miracles: Th17 cells in the intestine

  2012influential reference
• Probiotic Bifidobacterium breve Induces IL-10-Producing Tr1 Cells in the Colon

  2012cited by this paper
• Intestinal commensal microbes as immune modulators.

  2012cited by this paper
• Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury

  2011cited by this paper
• NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis.

  2011influential reference
• Microbial Dysbiosis in Colorectal Cancer (CRC) Patients

  2011cited by this paper
• Effect of Cavity Design on the Strength of Direct Posterior Composite Restorations: An Empirical and FEM Analysis

  2011cited by this paper
• Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis

  2011cited by this paper
• Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22

  2011cited by this paper
• Th17 cells express interleukin-10 receptor and are controlled by Foxp3⁻ and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner.

  2011cited by this paper
• Helicobacter hepaticus infection in mice: models for understanding lower bowel inflammation and cancer

  2010cited by this paper
• The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer

  2010influential reference
• MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18

  2010cited by this paper
• The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis.

  2010influential reference
• Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis

  2010cited by this paper
• Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4

  2010cited by this paper
• Induction of intestinal Th17 cells by segmented filamentous bacteria.

  2009cited by this paper
• Toll-like receptors and cancer

  2009cited by this paper
• A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses

  2009cited by this paper
• Pattern recognition receptors and control of adaptive immunity

  2009cited by this paper
• ATP drives lamina propria TH17 cell differentiation

  2008cited by this paper
• Colorectal carcinogenesis in germ-free and conventionally reared rats: different intestinal environments affect the systemic immunity.

  2008cited by this paper
• Tumor-specific Th17-polarized cells eradicate large established melanoma.

  2008cited by this paper
• A microbial symbiosis factor prevents intestinal inflammatory disease

  2008cited by this paper
• Qualitative and quantitative analyses of the bifidobacterial microbiota in the colonic mucosa of patients with colorectal cancer, diverticulitis and inflammatory bowel disease.

  2007cited by this paper
• Toll-like receptors and innate immunity

  2006cited by this paper
• IL-23 promotes tumour incidence and growth

  2006cited by this paper
• CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice.

  2005influential reference
• Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine

  2004cited by this paper
• CD4(+)CD25(+) regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice.

  2003cited by this paper
• Toll-like receptors and innate immunity

  2001cited by this paper
• Animal models for the study of dietary factors and cancer of the large bowel.

  1975cited by this paper

• Role and mechanism of gut microbiota in regulating interferon-mediated programmed cell death in colorectal cancer

  2026cites this paper
• Clinical validation and utility of targeted nanopore sequencing for rapid pathogen diagnosis and precision therapy in lung cancer patients with pulmonary infections

  2026cites this paper
• Association of oral microbiota and digestive system cancers revealed by bidirectional two sample Mendelian randomization

  2026cites this paper
• Overview of tumor-resident intratumoral microbiota in human bladder cancer

  2026cites this paper
• The microbiome in cancer

  2025cites this paper
• Porphyromonas gingivalis and Fusobacterium nucleatum synergistically strengthen the effect of promoting oral squamous cell carcinoma progression

  2025cites this paper
• Interplay between bile acids, gut microbiota, and the tumor immune microenvironment: mechanistic insights and therapeutic strategies

  2025cites this paper
• The role of Gram‐positive cocci in cancer initiation, progression, and its application in therapy

  2025cites this paper
• The cancer microbiome.

  2025cites this paper
• Intratumoral Lipopolysaccharide Positivity Related to Tumor-Associated Macrophage Infiltration and Poor Prognosis in Esophageal Squamous Cell Carcinoma

  2025cites this paper
• A Study on the Microbiome within Oropharyngeal Cancer Tissues

  2025cites this paper
• Crosstalk between metabolic reprogramming and microbiota: implications for cancer progression and novel therapeutic opportunities

  2025cites this paper
• Exploring the potential effects of Lactococcus lactis D4 on the proliferation, apoptosis, and inflammatory responses in colorectal cancer cells

  2025cites this paper
• ARL6IP5 in cancers: bidirectional function and therapeutic value

  2025cites this paper
• Targeting the Tumor Microbiota in Cancer Therapy Basing on Nanomaterials

  2025cites this paper
• Progress in the Study of Intratumoral Microorganisms in Hepatocellular Carcinoma

  2025cites this paper
• Decoding the microbial-local immune dialogue in liver cancer: from ecological drivers to precision therapeutics

  2025cites this paper
• Pan-cancer analysis reveals intratumoral microbial diversity in multiple cancers by amplicon technology

  2025cites this paper
• Drug delivery systems for enhanced tumour treatment by eliminating intra-tumoral bacteria.

  2024cites this paper
• Microbiomas y salud humana

  2024cites this paper
• Intratumor microbiota and colorectal cancer: Comprehensive and lucid review.

  2024cites this paper
• Ellagic acid-protein nano-complex inhibits tumor growth by reducing the intratumor bacteria and inhibiting histamine production.

  2024cites this paper
• Microbiome in urologic neoplasms: focusing on tumor immunity

  2024cites this paper
• Copper-doped TiO2 nanocomposites: A dual functional nanoprobe for enhanced photodynamic therapy of breast tumor and antibacterial applications

  2024cites this paper
• Crosstalk Between the Intratumoral Microbiota and the Tumor Microenvironment: New Frontiers in Solid Tumor Progression and Treatment

  2024cites this paper
• The oncomicrobiome: new insights into microorganisms in cancer.

  2024cites this paper
• Clinical relationships between the intratumoral microbiome and risk factors for head and neck cancer

  2024cites this paper
• Intratumoral microbiota as cancer therapeutic target

  2024cites this paper
• Research Progress of Intratumoral Microbiota

  2024cites this paper
• Identification of RCAN1’s role in hepatocellular carcinoma using single-cell analysis

  2024cites this paper
• Targeting bacterial metabolites in tumor for cancer therapy: An alternative approach for targeting tumor-associated bacteria.

  2024cites this paper
• Gut Microbial Dysbiosis in the Pathogenesis of Leukemia: An Immune-based Perspective.

  2024cites this paper
• Intratumoral microorganisms in tumors of the digestive system

  2024cites this paper
• When smoke meets gut: deciphering the interactions between tobacco smoking and gut microbiota in disease development

  2024cites this paper
• Intratumoural microbiota: a new frontier in cancer development and therapy

  2024cites this paper
• Concentration of Selected Adipokines and Factors Regulating Carbohydrate Metabolism in Patients with Head and Neck Cancer in Respect to Their Body Mass Index

  2023cites this paper
• The emerging tumor microbe microenvironment: From delineation to multidisciplinary approach-based interventions

  2023cites this paper
• Bacteria-Nanodrug Cancer Treatment System: The Combination of Dual Swords and the Confrontation of Needle Tips

  2023cites this paper
• The role of oral microbiota in cancer

  2023cites this paper
• Intratumor microbiota in cancer pathogenesis and immunity: from mechanisms of action to therapeutic opportunities

  2023cites this paper
• Inactivation of TRPM7 Kinase Targets AKT Signaling and Cyclooxygenase-2 Expression in Human CML Cells

  2023cites this paper
• Advances in the role of gut microbiota in the regulation of the tumor microenvironment (Review)

  2023cites this paper
• Intratumoural microbiota: from theory to clinical application

  2023cites this paper
• Modulation of Intratumoral Fusobacterium nucleatum to Enhance Sonodynamic Therapy for Colorectal Cancer with Reduced Phototoxic Skin Injury

  2023cites this paper
• Inhalable GSH-Triggered Nanoparticles to Treat Commensal Bacterial Infection in In Situ Lung Tumors.

  2023cites this paper
• The Colorectal Cancer Microbiota Alter Their Transcriptome To Adapt to the Acidity, Reactive Oxygen Species, and Metabolite Availability of Gut Microenvironments

  2023cites this paper
• New Trends in Interrelation of Infectious Colorectal Cancer with Intestinal Microbiota

  2022cites this paper
• Effect of Swimming on Gut Microbiota and Inflammation in Colorectal Cancer Cells Transplanted Mice

  2022cites this paper
• A promising research direction for colorectal cancer immunotherapy: The regulatory mechanism of CCL5 in colorectal cancer

  2022cites this paper
• A literature review on the potential clinical implications of streptococci in gastric cancer

  2022cites this paper
• Inflammatory Cytokine: An Attractive Target for Cancer Treatment

  2022cites this paper
• Therapeutic approaches to colorectal cancer via strategies based on modulation of gut microbiota

  2022cites this paper
• Emerging role of human microbiome in cancer development and response to therapy: special focus on intestinal microflora

  2022cites this paper
• Microbiota in Tumors: From Understanding to Application

  2022cites this paper
• The microbiome restrains melanoma bone growth by promoting intestinal NK and Th1 cell homing to bone

  2022cites this paper
• The role of microbiota and immune system crosstalk in cancer development and therapy.

  2022cites this paper
• Noncoding RNAs Serve as the Deadliest Universal Regulators of all Cancers

  2021cites this paper
• The role of Th17 cells in viral infections.

  2021cites this paper
• Gut microbiota influence tumor development and Alter interactions with the human immune system

  2021cites this paper
• Noncoding RNAs and Deep Learning Neural Network Discriminate Multi-Cancer Types

  2021cites this paper
• Oral microbiota and Helicobacter pylori in gastric carcinogenesis: what do we know and where next?

  2021cites this paper
• Inhibitory Effects of Breast Milk-Derived Lactobacillus rhamnosus Probio-M9 on Colitis-Associated Carcinogenesis by Restoration of the Gut Microbiota in a Mouse Model

  2021cites this paper
• Microbiome–miRNA interactions in the progress from undifferentiated arthritis to rheumatoid arthritis: evidence, hypotheses, and opportunities

  2021cites this paper
• A Comparison Study of Age and Colorectal Cancer-Related Gut Bacteria

  2021cites this paper
• Impact of the Gut Microbiota Balance on the Health–Disease Relationship: The Importance of Consuming Probiotics and Prebiotics

  2021influential citation
• Vitamin D and The Gut Microbiota: a Narrative Literature Review

  2021cites this paper
• Oral and gastric microbiome in relation to gastric intestinal metaplasia

  2021cites this paper
• Microbiome Crosstalk in Immunotherapy and Antiangiogenesis Therapy

  2021cites this paper
• Expression of Th17 axis as a biomarker panel in diagnosis and prognosis of colorectal cancer

  2021cites this paper
• Role of interleukin-17 in human papillomavirus infection and associated malignancies.

  2021cites this paper
• Cancer Microbiology.

  2021cites this paper
• The Differential Expression of the Inflammasomes in Adipose Tissue and Colon Influences the Development of Colon Cancer in a Context of Obesity by Regulating Intestinal Inflammation

  2021cites this paper
• Toll-like receptor 4 prevents AOM/DSS-induced colitis-associated colorectal cancer in Bacteroides fragilis gnotobiotic mice

  2020cites this paper
• New insight into 20(S)-ginsenoside Rh2 against T-cell acute lymphoblastic leukemia associated with the gut microbiota and the immune system.

  2020cites this paper
• Association between the gut microbiota and patient responses to cancer immune checkpoint inhibitors

  2020influential citation
• Significant and Conflicting Correlation of IL-9 With Prevotella and Bacteroides in Human Colorectal Cancer

  2020cites this paper
• Gene Expression Analysis of Human Papillomavirus-Associated Colorectal Carcinoma

  2020cites this paper
• Gut Microbiota Contributes to Spontaneous Colitis in E3 Ligase Itch-Deficient Mice

  2020cites this paper
• The Link "Cancer and autoimmune diseases" in the light of microbiota: evidence of a potential culprit.

  2020cites this paper
• Colorectal cancer and the microbiome: dysplasia, probiotics, and Fusobacterium nucleatum

  2020cites this paper
• Microbiota, mucosal immunity, and Colon cancer

  2020cites this paper
• Microbiota-Propelled T Helper 17 Cells in Inflammatory Diseases and Cancer

  2020cites this paper
• Vitamin D Signaling in Inflammation and Cancer: Molecular Mechanisms and Therapeutic Implications

  2020cites this paper
• A Comparison of Tumor-Associated and Non-Tumor-Associated Gastric Microbiota in Gastric Cancer Patients

  2020cites this paper
• Differential expression and significance of Stat3 and IL-17 in gastritis and gastric intraepithelial neoplasia and gastric cancer

  2020cites this paper
• Gut Microbiota Shapes the Efficiency of Cancer Therapy

  2019cites this paper
• Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis.

  2019cites this paper
• Microbiota and cancer: an update

  2019cites this paper
• Two Strains of Lactobacilli Effectively Decrease the Colonization of VRE in a Mouse Model

  2019cites this paper
• The Microbiota and Ovarian Cancer

  2019cites this paper
• Primary Immunodeficiency and Cancer Predisposition Revisited: Embedding Two Closely Related Concepts Into an Integrative Conceptual Framework

  2019cites this paper
• Transmissible inflammation-induced colorectal cancer in inflammasome-deficient mice

  2019cites this paper
• Colorectal Cancer Prevention

  2019cites this paper
• The germ-free mice monocolonization with Bacteroides fragilis improves azoxymethane/dextran sulfate sodium induced colitis-associated colorectal cancer

  2019cites this paper
• Early-Life Microbiota Exposure Restricts Myeloid-Derived Suppressor Cell–Driven Colonic Tumorigenesis

  2019cites this paper
• Ethyl‐N‐dodecanoyl‐l‐arginate hydrochloride combats pathogens with low‐resistance generation by membrane attack and modifies gut microbiota structure

  2019cites this paper
• Gastrointestinal tract dysbiosis enhances distal tumor progression through suppression of leukocyte trafficking.

  2019cites this paper
• Alterations to the Esophageal Microbiome Associated with Progression from Barrett's Esophagus to Esophageal Adenocarcinoma

  2019cites this paper
• Mapping Interactions of Microbial Metabolites with Human G-Protein-Coupled Receptors

  2019cites this paper
• Patterned progression of gut microbiota associated with necrotizing enterocolitis and late onset sepsis in preterm infants: a prospective study in a Chinese neonatal intensive care unit

  2019cites this paper